Skip to content
Review

Cancer-Associated Fibroblasts and Tertiary Lymphoid Structures: Critical Regulators in the Tumor Immune Microenvironment.

Nov 2026 · Critical reviews in oncology/hematology · pp. 105688 · 0 citations · 99 references
Medicine

Abstract

Tumor-associated fibroblasts (CAFs) are a highly heterogeneous cell population. Although previous studies have largely associated CAFs with tumor invasion and drug resistance, recent evidence has linked certain CAFs subsets to tertiary lymphoid structures (TLS) within the tumor immune microenvironment. TLS are lymphocyte aggregates that form in various solid tumors, and their density and location are closely associated with treatment response and prognosis. However, specific studies on CAFs within the TLS niche remain limited and fragmented, underscoring an urgent need for systematic synthesis. By reviewing recent advances in relevant studies, we innovatively propose a "CAFs-TLS axis" framework. This framework does not claim to uncover new biological mechanisms; rather, it summarizes the distinct CAFs subsets within the TLS niche and elaborates on how CAFs participate in or suppress the entire process of TLS initiation, recruitment, maturation, and re-aggregation. We further discuss how different therapeutic strategies affect the "CAFs-TLS axis." This framework will provide a theoretical basis for developing strategies that target CAFs to induce TLS formation, enhance therapeutic efficacy, and strengthen antitumor immune responses, ultimately improving clinical outcomes for cancer patients.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.